Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation (for Nebraska Only)

Coverage Summary

Scope: This is a Nebraska‑only UnitedHealthcare medical policy (CS036NE.T, effective March 1, 2025) that addresses coverage and medical necessity criteria for a range of electrical stimulation modalities including TENS, FES, NMES, and other modalities (IFT, MENS, PENS/PENFS, PNS, PSFS/PNFS, PES/PEMF, restorative neurostimulation, Scrambler Therapy, TLS/PoNS). The policy takes a mixed coverage stance: it identifies a single proven FES indication — FES as a medically necessary component of comprehensive ambulation rehabilitation for individuals with lower‑limb paralysis from spinal cord injury (SCI) when ALL specified criteria are met — while listing many other modalities as unproven / not medically necessary due to insufficient evidence of efficacy.

Key policy thresholds and high-level summary

Policy numberCS036NE.T

Effective dateMarch 1, 2025

Scope summaryNebraska-only UnitedHealthcare medical policy covering TENS, FES, NMES and other electrical stimulation modalities; specifies indications, clinical coverage references, applicable procedure and HCPCS/DME/supply codes and device guidance

Threshold - Independent standing tolerance>= 3 minutes (required for FES ambulation in SCI)

Threshold - Post-recovery interval for SCI>= 6 months (post-recovery/restorative surgery required for FES ambulation)

Headline - Overall Evidence QualityOverall evidence quality: mixed / generally low-to-moderate; short-term benefit signals for some modalities; insufficient/low-quality evidence for many indications

Medical Necessity Criteria

Functional Electrical Stimulation (FES) - Medically Necessary for Ambulation Rehabilitation in SCI

FES is proven and medically necessary as part of a comprehensive ambulation rehabilitation program for individuals with lower limb paralysis due to spinal cord injury (SCI) when ALL criteria below are met.

FES - SCI ambulation criteria

Intact motor units: Demonstration of intact lower motor units (L1 and below) (both muscle and peripheral nerves)
Muscle/joint stability: Muscle and joint stability for weight bearing at upper and lower extremities that can demonstrate balance and control to maintain an upright support posture independently
Brisk contraction: Demonstration of brisk muscle contraction

Evidence Synthesis & Guideline Summaries

Background and device categories: The policy defines multiple electrical stimulation categories and their proposed mechanisms and clinical uses. Examples include FES (direct coordinated stimulation of motor neurons to produce purposeful contraction for functions such as standing, ambulation, grasping, and exercise), NMES (transcutaneous currents to evoke muscle contraction for reinnervation, prevent atrophy, and promote voluntary control), TENS (surface electrodes to decrease perception of pain via inhibition of afferent pain transmission and/or endorphin release), PENS/PNT (acu‑needle/percutaneous stimulation connected to external power for pain modulation), PENFS (auricular/field stimulation targeting cranial neurovascular bundles), PNS/PSFS/PNFS (electrodes implanted or placed near peripheral nerves or in subcutaneous tissue), IFT (interferential currents for deeper penetration and pain relief), MENS (microampere currents for pain/healing claims), PES/PEMF (pulsed electrical/magnetic fields hypothesized to affect bone/cartilage and soft-tissue healing), restorative neurostimulation (implantable multifidus stimulation for mechanical CLBP), Scrambler Therapy (transcutaneous electrical modulation pain reprocessing), and TLS/PoNS (translingual tongue stimulation to augment neuroplasticity).

Evidence summaries (PENFS / PNS / PES-PEMF)

Summaries of clinical studies and systematic reviews assessing PENFS/PNS/PES-PEMF and limitations.

PENFS / PNS / PES-PEMF summaries

Applicable Codes

Procedure codes referenced (informational)CPT

0278T	Transcutaneous electrical modulation pain reprocessing (e.g., scrambler therapy), each treatment session (includes placement of electrodes)
0720T	Percutaneous electrical nerve field stimulation, cranial nerves, without implantation
0783T	Transcutaneous auricular neurostimulation, set-up, calibration, and patient education on use of equipment
63650	Percutaneous implantation of neurostimulator electrode array, epidural
63655	Laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural
63663	Revision including replacement, when performed, of spinal neurostimulator electrode percutaneous array(s), including fluoroscopy, when performed
63664	Revision including replacement, when performed, of spinal neurostimulator electrode plate/paddle(s) placed via laminotomy or laminectomy, including fluoroscopy, when performed
63685	Insertion or replacement of spinal neurostimulator pulse generator or receiver, requiring pocket creation and connection between electrode array and pulse generator or receiver
64555	Percutaneous implantation of neurostimulator electrode array; peripheral nerve (excludes sacral nerve)
64596	Insertion or replacement of percutaneous electrode array, peripheral nerve, with integrated neurostimulator, including imaging guidance, when performed; initial electrode array

1–10 of 13

1/2

HCPCS / DME / Supply codes (referenced)HCPCS

A4438	Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each
A4543	Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month
A4544	Electrode for external lower extremity nerve stimulator for restless legs syndrome
A4556	Electrodes (e.g., apnea monitor), per pair
A4557	Lead wires (e.g., apnea monitor), per pair
A4593	Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, controller
A4594	Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece, each
A4595	Electrical stimulator supplies, 2 lead, per month, (e.g., TENS, NMES)
E0720	Transcutaneous electrical nerve stimulation (TENS) device, two-lead, localized stimulation
E0721	Transcutaneous electrical nerve stimulator, for nerves in the auricular region

1–10 of 28

1/3

FES devices verified for HCPCS E0770 (per CMS PDAC)mixed

NESS L300	Bioness - NESS L300 and H200 devices (verified to be reported with HCPCS E0770)
H200	Bioness - see NESS L300/H200
Odstock ODFS Pace	Odstock Medical/Boston Brace - ODFS Pace FES System
WalkAide	Innovative Neurotronics - WalkAide
Deluxe Digital Electronic Muscle Stimulator	Drive Medical - Deluxe Digital Electronic Muscle Stimulator

Added HCPCS codes (applicable codes)HCPCS

A4543	Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month
A4544	Electrode for external lower extremity nerve stimulator for restless legs syndrome
E0721	Transcutaneous electrical nerve stimulator, for nerves in the auricular region
E0743	External lower extremity nerve stimulator for restless legs syndrome, each

Other referenced codes (noted in policy)HCPCS

NUH	Code NUH (referenced in source; ensure coding systems/mappings per payer rules)
NGX	Code NGX (referenced in source; ensure coding systems/mappings per payer rules)

Provider billing guidance: Report E0770 per CMS PDAC device reporting guidance — only devices verified by PDAC should be reported with E0770. The HCPCS codes A4543, A4544, E0721 and E0743 were added per the policy changes list. Ensure NUH and NGX codes are mapped appropriately in billing systems and follow state DMEPOS and contractual requirements when submitting claims.

Provider Actions & Billing Guidance

Documentation Required

Use Nebraska DMEPOS criteria for TENS/NMES medical necessity

Providers must refer to Nebraska Department of Health and Human Services, Code 471-7-000 (DMEPOS) for clinical coverage criteria and documentation supporting medical necessity for TENS and NMES.

Documentation Required

Document FES eligibility criteria for SCI

For FES for ambulation in SCI, document all required eligibility criteria:

Demonstration of intact lower motor units (L1 and below) (both muscle and peripheral nerves)
Muscle and joint stability for weight bearing with balance and control to maintain upright support independently
Demonstration of brisk muscle contraction

Definitions

Term	Definition
{"text":"FES","status":""},{"text":"Functional electrical stimulation: direct application of electric current to intact nerve fibers to produce purposeful muscle contraction to enable standing, ambulation, or other functions.","status":""}
{"text":"NMES","status":""},{"text":"Neuromuscular electrical stimulation: transcutaneous electrical currents to cause muscle contractions for reinnervation, preventing atrophy, and promoting voluntary control.","status":""}
{"text":"TENS","status":""},{"text":"Transcutaneous electrical nerve stimulation: surface electrodes deliver electrical current to decrease perception of pain by inhibiting afferent pain transmission and/or stimulating endorphin release.","status":""}
{"text":"PENS","status":""},{"text":"Percutaneous electrical nerve stimulation / percutaneous neuromodulation therapy: needles inserted percutaneously connected to external power source to treat pain.","status":""}
{"text":"PENFS","status":""},{"text":"Percutaneous electrical nerve field stimulation: variation of PENS targeting broader area (e.g., cranial neurovascular bundles) often in the external ear.","status":""}
{"text":"PSFS","status":""},{"text":"Peripheral subcutaneous field stimulation (also PNFS): electrode arrays implanted in subcutaneous tissue of painful area to stimulate cutaneous nerve endings rather than identified neural structures.","status":""}
{"text":"PNS","status":""},{"text":"Peripheral nerve stimulation: implanted or percutaneous electrode(s) placed near a peripheral nerve delivering impulses to disrupt transmission of pain signals (includes restorative neurostimulation/ReActiv8 as a form of PNS).","status":""}
{"text":"PEMF","status":""},{"text":"Pulsed electromagnetic field (PEMF) / pulsed electrical stimulation (PES): noninvasive electromagnetic or pulsed electrical fields hypothesized to facilitate tissue healing, reduce pain, or improve function.","status":""}
{"text":"MENS","status":""},{"text":"Microcurrent electrical nerve stimulation (MENS): very low amplitude (microamp) currents intended for pain relief and to facilitate healing; categorized regulatory as TENS but operates at sub-sensory currents.","status":""}
{"text":"IFT","status":""},{"text":"Interferential therapy (IFT/IFC): two medium-frequency pulsed currents delivered via skin electrodes producing a low-frequency current thought to relieve musculoskeletal pain and affect soft tissue.","status":""}
{"text":"Scrambler","status":""},{"text":"Scrambler Therapy (also transcutaneous electrical modulation pain reprocessing): noninvasive transdermal treatment applying variable nonlinear waveforms via electrodes to provide non-pain information to painful dermatomes.","status":""}
{"text":"Restorative neurostimulation / ReActiv8","status":""},{"text":"Restorative neurostimulation: implanted system (ReActiv8) that stimulates the multifidus via medial branch leads to restore neuromuscular control for refractory mechanical chronic low back pain.","status":""}
{"text":"PoNS/TLNS","status":""},{"text":"PoNS / Translingual neural stimulation (TLNS): portable neuromodulation stimulator delivering stimulation to the tongue (translingual) as adjunct to supervised therapeutic exercise for gait/balance deficits.","status":""}
{"text":"IFT (synonym IFC)","status":""},{"text":"Interferential current (IFC) synonym used interchangeably with IFT; medium-frequency alternating currents for pain relief.","status":""}
{"text":"PNFS","status":""},{"text":"Peripheral nerve field stimulation (PNFS) — see PSFS; stimulation of a broader field when a discrete peripheral nerve target is not appropriate.","status":""}
{"text":"PES","status":""},{"text":"Pulsed electrical stimulation (PES): electrical regimens hypothesized to facilitate bone, cartilage, and inflammatory cell function via induced fields.","status":""}
{"text":"PoNS","status":""},{"text":"Portable Neuromodulation Stimulator (PoNS): translingual neuromuscular tongue stimulator granted De Novo for short-term adjunct treatment of gait deficit in mild-moderate MS.","status":""}

Evidence Items & References

Evidence and references: The policy includes an evidence[] section citing multiple systematic reviews, randomized controlled trials, health technology assessments (Hayes, ECRI), and device regulatory summaries (FDA PMA/De Novo/510(k)) across modalities. Readers are advised to consult the full reference list and HTA summaries in the policy for details when evaluating clinical evidence and coverage decisions.

Reference	Finding/Value
{"text":"Hayes EARB (2024)","status":""},{"text":"Concluded insufficient peer‑reviewed literature to evaluate home‑based FES for SCI rehabilitation (no/unclear support).","status":""}
{"text":"ReActiv8 PMA","status":""},{"text":"ReActiv8 granted FDA Premarket Approval June 16, 2020 (implantable restorative neurostimulation for intractable CLBP; product code QLK); pivotal RCT ReActiv8-B reported 64% ≥50% LBP improvement and ODI/disability gains.","status":""}
{"text":"PoNS De Novo","status":""},{"text":"PoNS device granted De Novo approval March 25, 2021 for short‑term adjunct to supervised exercise for gait deficit due to mild‑moderate MS (patients ≥22 years).","status":""}
{"text":"IB‑Stim approval","status":""},{"text":"IB‑Stim (PENFS) FDA approval June 7, 2019 (DEN180057 / product code QHH) for functional abdominal pain in adolescents with IBS.","status":""}
{"text":"Largest RCT (ReActiv8-B footnote)","status":""},{"text":"ReActiv8-B pivotal RCT (n=240): primary outcomes included percent with ≥50% LBP reduction (reported 64%) and mean disability improvements; 4% serious adverse events.","status":""}
{"text":"Notable follow‑up (Gilligan 5‑yr)","status":""},{"text":"Five‑year ReActiv8 follow‑up: sustained improvements (e.g., VAS from 7.3 to 2.4; 71.8% ≥50% pain reduction) though attrition and explants noted.","status":""}

Medicare Determinations

Effective Date	Name	Type/Number
{"text":"2019-09-05","status":""},{"text":"Functional Electrical Stimulation (FES) - Coverage and HCPCS Coding - Revised","status":""},{"text":"NCD (Centers for Medicare & Medicaid Services guidance referenced by CMS/contractor link)","status":""}

Revision History

2025-03-01effectiveLatest

Policy effective date set to March 1, 2025.

03/01/2025added

Added HCPCS codes A4543, A4544, E0721, and E0743 to the Applicable Codes / HCPCS section (material change).

10/01/2025revised

Updated reference links to reflect current policy titles for related Nebraska policies: Implanted Electrical Stimulator for Spinal Cord and Occipital Nerve Injections and Ablation.